secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0000950170-23-028900
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics stockholders elect Garo Armen and Barbara Ryan as Class II directors, ratify KPMG as auditor
--------------------------------------------------------------------------------

- Garo Armen received 29,157,446 for and 282,326 withheld; Barbara Ryan 29,193,530 for and 246,242 withheld.
- KPMG LLP ratified as independent auditor for FY2023 with 30,644,494 for, 5,764 against, 110,413 abstentions.
- Quorum of 30,760,671 shares (89.6% of outstanding) present at June 13, 2023 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/inkt-20230613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-028900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer